New Delhi: The Centre has granted approval for the commercial exports of Bharat Biotech-manufactured COVID vaccine, Covaxin, in light of adequate stocks of the vaccine available with the states, reported News18.
According to the website’s sources, the Hyderabad-based vaccine manufacturer will export 108 lakh Covaxin doses commercially. Officials in the know of the development, however, said the Centre will decide on the quantity of vaccines to be exported based on domestic availability each month.
Covaxin is likely to be exported to eight countries — Paraguay, Botswana, Vietnam, Myanmar, Philippines, Singapore, Cameroon and the UAE.
ALSO READ: Will Covaxin, Covishield Be Effective Against Omicron Variant?
Bhubaneswar: Police have seized huge amount of explosive materials from a firecracker manufacturing unit in…
Cuttack: The Orissa High Court has extended the interim protection to BJD MLA and former…
New Delhi: The verbal duel between Trinamool Congress (TMC) and Bharatiya Janata Party (BJP) escalated…
New Delhi: A day after Delhi Chief Minister Arvind Kejriwal's ED remand was extended till…
Bhubaneswar: Odisha is likely to experience hot and humid weather conditions during the next 4-5…
New Delhi: In another blow to cash-strapped Congress ahead of the Lok Sabha polls, the…
New Delhi: The Central Bureau of Investigation (CBI) has filed a closure report in the…
Bhubaneswar: A day after resigning from Congress, former minister Surendra Singh Bhoi on Friday joined…